AR and prostate carcinoma: High (LNCaP) and low (DU‐145) expressing AR prostatic cancer cell lines used as positive and negative controls, respectively, exhibited similar patterns of AR receptor expression to the HTB‐131 and HTB‐132 cell lines, respectively.